Drugs Market Research Reports & Industry Analysis

FirstWord’s Trends and Innovations in Drug Pricing report dissects international trends and examines how long-standing dynamics in competitive pricing and ... research and expert interviews, Trends and Innovations in Drug Pricing is an open window to the future of drug pricing. Worldwide, the trend towards payers determining price has ...

... quotation of cholesterol and vitamin D3 (VD3). Garden Biochemical, one of the largest manufacturers of VD3 in the world, the supply of VD3 was in short, ... and project basic information, suggestion or prospect analysis. What to report: In this report, some of the most relevant domestic vitamin projects have ...

... in various ways. In this report, development situation of vitamin listed companies has been described in detail, including company profile, financial performance, product mix, market share ...

... also Physician Views: What opportunity for biosimilar basal insulin?), we are polling US and EU5-based endocrinologists to gauge their assessment of new long-acting insulins ... Lantus sales will be flat next year (due most likely to greater rebating with payers) and the potential leverage their availability will ...

... a direct analyse of China's vitamin trade flows around the volume, price, partners, and an indirect description of industry changes. What to report: In this report, import and export of China's vitamins in 2013 and ...

... Hepatitis C Pipeline Drugs - Clinical Trials The report gives an insight on the Hepatitis C Deals and Acquisitions (2004 - 2014) iGATE RESEARCH report entitled Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Analysis to 2019 provides an in-depth analysis of the drugs, pipeline drugs and the key players ...

... drugs would meet orphan drug criteria. Orphan Drugs are part of the clinical landscape and all stakeholders have valid interests which have to be addressed now. Orphan Drug Market Access: Payer Insights on the Present and Future offers insights from US and European healthcare payers and includes illustrative case ...

... field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Worldwide market for drug discovery technologies explored in this study includes Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, ...

... disorders, which are extremely life-threatening. As per the official definition, rare diseases are classified as those that affect fewer than 200, ... & FDA Regulatory Framework US Orphan Drug Pipeline by Phase, Indication & Company Marketed Orphan Drug Clinical Insight US Orphan Drug Clinical Pipeline: 570 ...

... purchasing Hard Copy License depending on the location. The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry ... with launch of novel drugs will drive the growth of CNS disease market in future. “US CNS Disorders Drug Pipeline Insight 2014” Report ...

... Global HIV Infection Drug Market & Pipeline Insight” Report Highlight: Global HIV Infection Drug Market Overview & Incidence Scenario FDA & EMA Regulation for Development of HIV Drug Global HIV Infection Drug Clinical Pipeline by Phase, Company & Country Global HIV Clinical Pipeline: 315 Drugs ...

... segmented the CIS Insulin market on the basis of product, application, source and region: CIS Insulin Product Outlook Rapid Acting Long Acting Premixed Premixed Analog Short Acting Intermediate Acting CIS Insulin Application ...

... are also being analyzed. A majority of these studies were previously focusing on cervical cells in women. But in recent years, the realm of research has ... lead to the growth of abnormal cells, thus controlling the incidence of cervical cancer. “Cervical Cancer Drug Market & Pipeline Insight” Report Highlights ...

... offers much potential for future prevention and cure over the next two decades. “Schizophrenia Drug Market & Pipeline Insight” Report Highlights: Schizophrenia Drug Market Overview Marketed Drug Profiles & Patent Analysis Clinical Trial Insight by Phase & Country Drug in Clinical Development Phase: ...

... in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR ... Outlook Human Recombinant Analogs Insulin Regional Outlook Brazil Argentina Chile Mexico Colombia Venezuela Peru Rest of Latin America

... titled “Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)” provides an insight into migraine drugs with a special focus on Triptans. The report also includes the market value ... generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of anti-migraine drugs market. Other ...

... the function and regulation of iron.The key factors driving growth of the global IV iron industry include escalating number of dialysis ... report analyzes the global iron products industry along with an extensive coverage of global and the US IV iron market. The global IV iron market witnesses intense ...

... top two consumers of feed water-soluble vitamins and minerals in the world, having collectively accounted for more than 61% and 53% of the consumption of feed water-soluble minerals and feed water-soluble vitamins, respectively, in 2012. Asia-Pacific is estimated to be the fastest-growing market for feed water-soluble minerals, in terms of value. Growth is particularly ...

... the diagnostic techniques as the researchers would get a deeper understanding of the disease. Thus, overall, there is significant amount of research currently underway for ... , it is most likely that this market would offer better solutions for the patients. “Crohn’s Disease Drug Market and Pipeline Analysis” ...

... as a result of continued initiatives to improve healthcare access. The Asia Pacific insulin market is oligopolistic in nature and is dominated by three key ... Insulin Regional Outlook India China Australia New Zealand South Korea Taiwan Philippines Vietnam Indonesia Japan Malaysia Thailand Rest of Asia Pacific

... insulin products by exhibiting higher efficacy. North America was the largest regional market ... insulin market on the basis of product, segment (on the basis of source), application and region: Insulin Product Outlook Fast Acting Insulin Short Acting Insulin Intermediate Acting Insulin Long Acting Insulin ...

... is forecasted to grow at a CAGR of over 10% during 2012-2018. Our RNCOS research report, “Global Insulin Market Outlook 2018”, has revealed that the ... comprehensive research work also studies how patent expiry of block buster insulin products would create opportunities for biosimilars. The report conducts an ...

... Produced by Different Enterprises in China Hospital Market Sales Value of Valsartan Hydrochlorothiazide in China Hospital Market Major Valsartan Hydrochlorothiazide Manufacturers in China Prospect of China Valsartan Hydrochlorothiazide Market The following enterprises and people are recommended to ...

... of Adalimumab in Hospital Market in China Price of Adalimumab Produced by Vetter Pharma Fertigung GmbH & Co. KG in China Hospital, 2014 Manufacturing Schedule of Adalimumab Generic Drug Prospect of China Adalimumab Market The following enterprises and people are recommended to purchase this report: ...

... China. According to CRI's market investigation, the sales revenue of Lyrica in Chinese sample hospital market grew over 100 times from 2010 to 2013. ... incidence of epilepsy is doomed to increase, which leads to a bright future for pregabalin market in China. Through this report, the readers can acquire the ...

... by kidney and liver that stimulates erythropoiesis. Indications of EOP approved in China are renal anemia, anemia after chemotherapy and surgery perioperative ... space for EPO used in anemia after chemotherapy in China. Originally developed by Amgen Inc., epoetin alfa was approved to the U.S. in June 1989 by ...

... approved to China in 2002 to treat CML and GIST. Its market size keeps increasing after its launch. According to CRI's investigation on sample ... Hospital Market Incidence of CML in China Manufacturing Schedule of Imatinib Generic Drug Prospect of China Imatinib Market The following enterprises and people ...

... the end of 2013 there have been over 10 million schizophrenia patients in China, and the number is still increasing year after year. Schizophrenia ... in Different Dosage Forms in China Hospital Market Prospect of China Aripiprazole Market The following enterprises and people are recommended to purchase this ...

... , and treat unstable angina and non-Q-wave myocardial infarction. Enoxaparin sodium generic drugs produced by Sandoz and Amphastar Pharm have ... Market Production Status of Enoxaparin Sodium Generic Drug in China Major Enoxaparin Sodium Manufacturers in China Prospect of China Enoxaparin Sodium Market The ...

... value keeps increasing year after year. The CAGR of sales value of pemetrexed was 50.6% from 2004 to 2011. The sales value was only ... China Hospital Market Incidence of Cancer in China Manufacturing Schedule of Pemetrexed generic drug Prospect of China Pemetrexed Market The following enterprises and people ...

... benchmarking research studying the cost structure of Chinese vitamin C and the competitiveness of major Chinese players. ... set up the model and verify afterwards. The breakeven price of Chinese products is concluded. The aim of ... as how to penetrate the ever-increasing China market and how to catch the maximum ...

... remedy. Public data shows that the global sales value of bevacizumab in 2012 exceeded USD 6.3 billion, ranking the fourth among the ... Dosage Forms in Hospital Market in China Incidence of Cancer in China Manufacturing Schedule of Bevacizumab generic drug Prospect of China Bevacizumab Market The author ...

... increasing, which nearly reached USD 5 billion in 2012. The success of duloxetine sales also comes from its persistent exploration and study ... in Different Dosage Forms in China Hospital Market Prospect of China Duloxetine Market The author recommends the report to the following: Antidepressant APIs ...

... can acquire the following information: Market Share of Major Valsartan Manufacturers in Sampling Hospitals in China Sales price of valsartan in hospital market in China Major valsartan enterprises in China Market share of valsartan by dosage form in hospital market in China Prospect of China valsartan ...

... orphan drugs. “Europe Orphan Drug Market Outlook 2018” research report by KuicK Research comprehensive insight on following developments related to Europe orphan drug market: Europe Orphan Drug Market Overview Orphan Drug Designation Criteria Market Specific Reimbursement Policy & Regulatory Framework Europe ...

... . “US Orphan Drug Market Outlook 2018” research report by KuicK Research comprehensive insight on following developments related to US orphan drug market: US Orphan Drug Market Overview Orphan Drug Designation Criteria Market Specific Reimbursement Policy & Regulatory Framework US Orphan Drug ...

... . “Global Radiopharmaceuticals Market Insight” Report Highlights Global Radio Pharmaceuticals Market Overview by Region arget Patient Base by Region Radiopharmaceuticals Market Regulation for US, Europe & Canada Radioisotopes Used in Radiopharmaceuticals Radiopharmaceutical Clinical Pipeline Insight ...

... Pipeline Analysis The report entitled Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis published in January 2014 is based on the evaluation of more ... arising from new site-specific and from polymer/nanoparticel-based conjugation systems and the most promising new payloads for ADCs. ...

... start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace ... , controls, calibrators and others. “2014 Analysis of the Global Drugs of Abuse Testing Market” is a unique study designed to help current suppliers and ...

... / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes Europe Alzheimer’s Disease Drug Pipeline by Clinical Phase: Research: 19 Preclinical: 49 Clinical: 1 Phase-I: 25 Phase-I/II: 2 Phase-II: 26 Phase-II/III: 2 Phase-III: 5 Preregistration: 2 Marketed: 10 Unknown: 1

... for Clinical Trial Owner / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes Europe Parkinson’s Disease Drug Pipeline by Clinical Phase: Research: 12 Clinical: 26 Phase-I: 14 Phase-I/II: 2 Phase-II: 6 Phase-II/III: 1 Phase-III: 3 Preregistration: 1 Marketed: 18

... Trial Owner / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes Number of Skin Cancer Drug in Pipeline by Clinical Phase: Research: 3 Preclinical: 29 Clinical: 5 Phase 0: 1 Phase-I: 29 Phase-I/II: 18 Phase-II: 41 Phase-III: 13 Registered: 4 Marketed: 18 Unknown: 1

... for the pharma companies in their every-day decision making. “Japan Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... to identify and analyze the available investment opportunity in the Japan cancer drug market based upon development process. Following parameters for ...

... identify and analyze the available investment opportunity in the Europe lung cancer drug market based upon development process. Following parameters for ... drug profile in development phase are covered in “Europe Lung Cancer Drug Pipeline Analysis” research report: Drug Profile Overview Alternate Names for ...

... in the Europe orphan designated drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Europe Orphan Drug Pipeline Analysis 2014” research report: Drug Profile Overview Active Indication ...

... pace of growth is not being reported in the area of development of drugs and therapies for treating cancers. The report also predicts that the ... analysis in the diagnosis and treatment of various types of cancer, clearing the path for personalized medicine towards becoming a common expression associated with ...

... Lilly, of which, Novo Nordisk accounted for 60.3% in 2012. While in recombinant human insulin market segments, the local Chinese enterprise –Tonghua Dongbao Pharmaceutical ... also received clinical approval issued by SFDA in September 2013. Global and China Insulin Industry Report, 2013-2017 mainly covers the ...

... markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “ ...

... markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “ ...

... markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “ ...